13F-HR filed by Rosalind Advisors, Inc.
Rosalind Advisors, Inc. filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-14, with 38 holding rows worth $248,888,076.
- Accession
- 0001622627-26-000015
- Filer
- CIK 1622627
- Filed
- 2026-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 38 entries on the cover page, a total value of $248,888,076 stated on the cover page (in dollars after the unit check, H1), rows summing to $248,888,076 with VALUE read as dollars as filed, 13F file number 028-23857. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 3,300,389 | $30,627,610 | dollars as filed | |
| XERIS BIOPHARMA HOLDINGS INC | 98422E103 | COM | 3,231,700 | $18,743,860 | dollars as filed | |
| FENNEC PHARMACEUTICALS INC | 31447P100 | COMMON STOCK | 2,908,201 | $17,885,436 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 3,203,721 | $17,492,317 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 290,000 | $16,851,900 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 1,036,737 | $13,363,540 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 3,214,766 | $13,276,984 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 700,000 | $12,488,000 | dollars as filed | |
| MEDIWOUND LTD | M68830112 | COMMON STOCK | 749,054 | $12,067,260 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 2,138,475 | $11,333,918 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 330,000 | $10,467,600 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 923,057 | $8,787,503 | dollars as filed | |
| CYBIN INC | 23256X407 | COM NEW | 1,531,814 | $7,352,707 | dollars as filed | |
| CG ONCOLOGY INC | 156944100 | COMMON STOCK | 100,000 | $6,768,000 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 3,905,743 | $6,366,361 | dollars as filed | |
| ATEA PHARMACEUTICALS INC | 04683R106 | COMMON STOCK | 1,171,855 | $6,304,580 | dollars as filed | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 828,118 | $5,366,205 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 250,401 | $4,897,844 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N906 | CALL | 1,275,600 | $2,746,725 | dollars as filed | call |
| POLYPID LTD | M8001Q126 | COM | 597,926 | $2,618,916 | dollars as filed | |
| MYOMO INC | 62857J201 | COM NEW | 3,847,272 | $2,599,217 | dollars as filed | |
| TALPHERA INC | 00444T209 | COM NEW | 3,353,916 | $2,505,040 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 1,107,994 | $2,459,747 | dollars as filed | |
| DEFINIUM THERAPEUTICS INC | 24477V105 | COM SHS | 125,000 | $2,362,500 | dollars as filed | |
| ONKURE THERAPEUTICS INC | 68277Q105 | COM CL A | 443,763 | $1,837,179 | dollars as filed | |
| LIPOCINE INC NEW | 53630X203 | COM NEW | 221,616 | $1,770,712 | dollars as filed | |
| NEURAXIS INC | 64134X201 | COM | 286,138 | $1,693,937 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 75,000 | $1,119,750 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 200,000 | $1,108,000 | dollars as filed | |
| INVESCO QQQ TR | 46090E953 | PUT | 250,000 | $1,053,000 | dollars as filed | put |
| AQUESTIVE THERAPEUTICS INC COM | 03843E104 | Stock | 250,000 | $1,037,500 | dollars as filed | |
| SPDR S&P 500 ETF TR | 78462F953 | PUT | 125,000 | $958,500 | dollars as filed | put |
| BIOFRONTERA INC | 09077D209 | COM NEW | 1,163,962 | $941,645 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 100,000 | $813,000 | dollars as filed | |
| REGENTIS BIOMATERIALS LTD | M8211G108 | ORDINARY SHARES | 251,510 | $768,363 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C954 | PUT | 263,600 | $52,720 | dollars as filed | put |
| UNIQURE NV | N90064901 | CALL | 295,800 | $0 | dollars as filed | callValue filed as zero, left out of ratios. |
| ARRIVENT BIOPHARMA INC | 04272N902 | COM | 108,900 | $0 | dollars as filed | callValue filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001622627-26-000015 | this filing | 2026-05-14 | acceptance time not in the bulk data set |